- Home
- JANX vs NSP Comparison
JANX vs NSP Comparison
Compare JANX & NSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JANX
- NSP
- Stock Information
- Founded
- JANX 2017
- NSP 1986
- Country
- JANX United States
- NSP United States
- Employees
- JANX N/A
- NSP N/A
- Industry
- JANX Biotechnology: Pharmaceutical Preparations
- NSP Professional Services
- Sector
- JANX Health Care
- NSP Consumer Discretionary
- Exchange
- JANX Nasdaq
- NSP Nasdaq
- Market Cap
- JANX 1.7B
- NSP 1.7B
- IPO Year
- JANX 2021
- NSP 1997
- Fundamental
- Price
- JANX $29.41
- NSP $32.76
- Analyst Decision
- JANX Strong Buy
- NSP Hold
- Analyst Count
- JANX 10
- NSP 3
- Target Price
- JANX $77.40
- NSP $47.67
- AVG Volume (30 Days)
- JANX 1.1M
- NSP 865.8K
- Earning Date
- JANX 11-06-2025
- NSP 11-03-2025
- Dividend Yield
- JANX N/A
- NSP 7.35%
- EPS Growth
- JANX N/A
- NSP N/A
- EPS
- JANX N/A
- NSP 0.45
- Revenue
- JANX $10,000,000.00
- NSP $6,757,000,000.00
- Revenue This Year
- JANX N/A
- NSP $5.06
- Revenue Next Year
- JANX $89.91
- NSP $5.35
- P/E Ratio
- JANX N/A
- NSP $73.00
- Revenue Growth
- JANX N/A
- NSP 3.19
- 52 Week Low
- JANX $21.73
- NSP $32.47
- 52 Week High
- JANX $71.71
- NSP $95.98
- Technical
- Relative Strength Index (RSI)
- JANX 58.15
- NSP 22.95
- Support Level
- JANX $26.96
- NSP $32.62
- Resistance Level
- JANX $29.53
- NSP $35.12
- Average True Range (ATR)
- JANX 2.10
- NSP 2.32
- MACD
- JANX 0.00
- NSP -0.64
- Stochastic Oscillator
- JANX 67.36
- NSP 1.99
About JANX Janux Therapeutics Inc.
Janux Therapeutics Inc is a clinical-stage biopharmaceutical company developing tumor-activated immunotherapies for cancer. Its proprietary technology has enabled the development of two distinct bispecific platforms: Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr). The TRACTr platform produces T cell engagers (TCEs) with a tumor antigen-binding domain and a CD3 T cell binding domain, while the TRACIr platform produces bispecifics with a tumor antigen-binding domain and a costimulatory CD28 binding domain.
About NSP Insperity Inc.
Insperity Inc is a company that provides a wide range of human resources and business solutions designed to help businesses improve their performance. Small and midsize enterprises are the company's primary target customers. Majority of the company's products are offered through the company's Workforce Optimization and Workforce Synchronization solutions, which comprise various human resource functions, such as payroll and employment administration, employee benefits and compensation, government compliance, performance management, training and development services, and human capital management. The company generates all of its revenue in the United States.